Trials
Search / Trial NCT00001364

Evaluation and Treatment of Patients Spinal Blood Vessel Abnormalities

Launched by NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE (NINDS) · Nov 3, 1999

Trial Information

Current as of March 16, 2025

Completed

Keywords

Spinal Arteriovenous Malformations Spinal Dural Arteriovenous Fistulas Surgery Embolization Spinal Arteriography

ClinConnect Summary

Spinal Arteriovenous Malformations are rare lesions that frequently effect young patients and adults in their most productive years. They cause progressive myelopathy, ultimately causing paraplegia or quadriplegia if untreated. Because they are rare lesions, experience with treating them in sufficient numbers to permit classification of them, investigation of the pathophysiology of myelopathy, and the introduction of new techniques for treatment has been possible in only a very few centers in this country. One essential element of investigation of them is selective spinal arteriography. Sin...

Gender

ALL

Eligibility criteria

  • * INCLUSION CRITERIA:
  • Adult greater than or equal to 18 years with known or suspected spinal AVM and capacity to provide written informed consent.
  • Child ages 4-18 with known or suspected spinal AVM and with parent/guardian informed consent.
  • EXCLUSION CRITERIA:
  • Unable to tolerate MRI and/or spinal arteriography.
  • Child less than 4 years.

About National Institute Of Neurological Disorders And Stroke (Ninds)

The National Institute of Neurological Disorders and Stroke (NINDS) is a leading component of the National Institutes of Health (NIH), dedicated to advancing our understanding of the brain and nervous system through innovative research. NINDS sponsors and conducts clinical trials aimed at developing effective treatments and improving patient outcomes for a wide range of neurological disorders, including stroke, epilepsy, multiple sclerosis, and neurodegenerative diseases. By fostering collaboration among researchers, healthcare providers, and patient communities, NINDS plays a pivotal role in transforming scientific discoveries into clinical applications, ultimately enhancing the quality of life for individuals affected by neurological conditions.

Locations

Bethesda, Maryland, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials